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Abstract
The peripheral auditory and vestibular systems rely on sensorineural structures that are vulnerable to ototoxic agents that 
cause hearing loss and/or equilibrium deficits. Although attention has focused on hair cell loss as the primary pathology 
underlying ototoxicity, evidence from the peripheral vestibular system indicates that hair cell loss during chronic exposure 
is preceded by synaptic uncoupling from the neurons and is potentially reversible. To determine if synaptic pathology also 
occurs in the peripheral auditory system, we examined the extent, time course, and reversibility of functional and morpho-
logical alterations in cochleae from mice exposed to 3,3′-iminodipropionitrile (IDPN) in drinking water for 2, 4 or 6 weeks. 
Functionally, IDPN exposure caused progressive high- to low-frequency hearing loss assessed by measurement of auditory 
brainstem response wave I absolute thresholds and amplitudes. The extent of hearing loss scaled with the magnitude of 
vestibular dysfunction assessed behaviorally. Morphologically, IDPN exposure caused progressive loss of outer hair cells 
(OHCs) and synapses between the inner hair cells (IHCs) and primary auditory neurons. In contrast, IHCs were spared from 
ototoxic damage. Importantly, hearing loss consistent with cochlear synaptopathy preceded loss of OHCs and synapses and, 
moreover, recovered if IDPN exposure was stopped before morphological pathology occurred. Our observations suggest that 
synaptic uncoupling, perhaps as an early phase of cochlear synaptopathy, also occurs in the peripheral auditory system in 
response to IDPN exposure. These findings identify novel mechanisms that contribute to the earliest stages of hearing loss 
in response to ototoxic agents and possibly other forms of acquired hearing loss.
Keywords Cochlea · Vestibule · Hair cell · Afferent synapse · Ototoxicity · Acquired hearing loss · Cochlear synaptopathy
Introduction
The auditory and vestibular systems in the inner ear rely on 
sensorineural structures that share many structural, molecu-
lar, and physiological features, including sensitivity to a vari-
ety of ototoxic agents that cause hearing loss and/or equilib-
rium deficits (Schacht et al. 2012). Aminoglycoside-induced 
auditory and vestibular toxicity have been demonstrated in 
both humans and animal models (Forge and Schacht 2000; 
Jiang et al. 2017; Van Hecke et al. 2017). In humans, the 
antineoplastic drug cisplatin is well known to cause hearing 
loss. In both humans and animal models, studies indicate 
that cisplatin is also toxic to the vestibular system (Callejo 
et al. 2017; Kitsigianis et al. 1988; Takimoto et al. 2016). 
Experimentally, several low molecular weight nitriles have 
also been demonstrated to be ototoxic (Crofton et al. 1994; 
Gagnaire et al. 2001; Llorens et al. 1993; Saldana-Ruiz et al. 
2012; Soler-Martin et al. 2007).
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In both the peripheral auditory and vestibular systems, 
ototoxic loss of the sensory hair cells (HCs) responsible 
for mechanotransduction has been particularly well docu-
mented. The vulnerability of HCs to ototoxicity varies 
depending on their subtype and also location within the 
sensory epithelia (Crofton et al. 1994; Forge and Schacht 
2000; Llorens et al. 1993; Schacht et al. 2012; Soler-Martin 
et al. 2007). For example, in the cochlea, outer HCs (OHCs) 
degenerate earlier and/or with lower doses than inner HCs 
(IHCs), and, in the vestibule, type I HCs are more suscep-
tible than type II HCs. Regionally, in the cochlea, the basal 
turns, which encode higher frequency sounds, are more vul-
nerable than the apical turns, which encode lower frequency 
sounds. Of the five sensory epithelia in the vestibule, the 
utricular macula and the three cristae in the semi-circular 
canals are more vulnerable than the saccular macula.
Although attention has historically focused on HC 
degeneration as the primary pathology underlying ototox-
icity, other pathologies have been recently identified. Evi-
dence from both rats (Sedó-Cabezón et al. 2015) and mice 
(Greguske et al. 2019) exposed to 3,3′-iminodipropionitrile 
(IDPN) in drinking water indicates that damage to the spe-
cialized synaptic contacts between the vestibular type I HCs 
and the calyx-shaped afferent endings of the vestibular neu-
rons is an early event in chronic vestibular toxicity. Spe-
cifically, in these studies, ototoxicity triggered the loss of 
adhesion proteins between the type I HCs and calyx afferent 
terminals as well as the loss of both presynaptic ribbons—
the specialized structures for neurotransmitter release from 
the HCs—and postsynaptic densities and postsynaptic gluta-
mate receptor clusters found on the calyx terminals. In both 
animal models, these pathological alterations were reversible 
if exposure was terminated promptly. Importantly, signifi-
cant vestibular dysfunction was associated with damage to 
the synaptic contacts and recovered following cessation of 
IDPN exposure, presumably due to synaptic recovery. Pre-
vious work in rats had shown that extended chronic IDPN 
exposure led to extrusion of the HCs (Seoane et al. 2001). 
Together, these findings suggest that synaptic uncoupling of 
the HCs from the afferent calyx terminals is the initial step 
in chronic ototoxic stress that precedes, and may trigger, 
extrusion, and finally loss of HCs.
Although evidence is more limited, a few studies suggest 
either directly or indirectly that synaptic uncoupling also 
plays a significant and primary role in ototoxicity in the audi-
tory system. First, post-mortem examination of patients who 
received either short- (Hinojosa and Lerner 1987) or long 
(Sone et al. 1998)-term treatment with aminoglycosides have 
identified temporal bones with either no or only scattered 
loss of HCs, but notable degeneration of the primary audi-
tory neurons—the type I spiral ganglion neurons (SGNs). 
Second, researchers examining mice exposed acutely to the 
aminoglycoside antibiotic gentamicin (in combination with 
the diuretic furosemide to potentiate aminoglycoside oto-
toxicity) found that the loss of the auditory neuron afferent 
dendrites contacting the IHCs preceded and also exceeded 
loss of the HCs; they hypothesized that gentamicin-induced 
damage to cochlear innervation occurs independently of HC 
loss (Ruan et al. 2014). Third, substantial evidence demon-
strates that the earliest and perhaps most common mecha-
nism of hearing impairment in response to noise exposure 
(Kujawa and Liberman 2009) and aging (Sergeyenko et al. 
2013) results not from loss of HCs but rather from cochlear 
synaptopathy, the loss of the synapses between the audi-
tory neuron afferent dendrites and the IHCs (Liberman and 
Kujawa 2017). Shared mechanisms underlie the triad of age-
related, noise-induced, and ototoxic hearing loss (Yang et al. 
2015) and excitotoxicity, in particular, may contribute to 
cochlear synaptopathy associated with ototoxicity (Basile 
et al. 1996; Duan et al. 2000). Thus, similar to the vestibular 
system, synaptic uncoupling may be the earliest and perhaps 
reversible pathology associated with ototoxicity in the audi-
tory system.
In this study, we examined the time course of functional 
and morphological alterations in the peripheral auditory 
system in response to chronic ototoxic exposure. We were 
particularly interested if and to what extent synaptic uncou-
pling and/or cochlear synaptopathy together with HC loss 
contributed to hearing loss and, moreover, if hearing loss 
was reversible following cessation of ototoxic exposure. To 
this end, we examined mice exposed chronically to IDPN 
in drinking water. IDPN is the best characterized ototoxic 
nitrile and induces both vestibular and auditory toxicity reli-
ably and dose-dependently in a variety of species (Crofton 
et al. 1994; Llorens et al. 1993; Llorens and Rodriguez-
Farre 1997; Seoane et al. 2001; Soler-Martin et al. 2007). 
We found that several pathological events, not only HC loss, 
are associated with hearing loss following IDPN exposure 
and that hearing loss recovered following limited exposure. 
These findings provide insight into the earliest and most 
reversible stages of ototoxicity and are likely shared by other 
forms of acquired hearing loss.
Materials and methods
Animals
All experiments were approved by the animal ethics com-
mittee of the University of Groningen (UG) and University 
Medical Center Groningen (UMCG) and complied with 
guidelines for animal experiments from the UG/UMCG, the 
Netherlands, and European animal welfare law. Male 129S2/
SvPasCrl mice (5 weeks of age) were obtained from Charles 
River (Germany) and housed in the UMCG central animal 
facility. Research examining the sex- and species-dependent 
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effects of IDPN exposure observed sufficient vestibular tox-
icity without excessive systemic toxicity in male 129S1/
SvImJ mice (Greguske et al. 2019). Therefore, only male 
mice were utilized in these experiments. Mice were housed 
in 12:12 h light:dark cycle and allowed ad libitum access 
to food and water. Mice were monitored daily and weighed 
weekly (Supplemental Table 1 and Supplemental Fig. 1). 
A total of 83 mice were used in these experiments. As 
described in more detail below, all mice underwent baseline 
assessment and then were divided into either a control group 
or an exposure group. Mice in both groups were re-assessed 
at 2, 4, and 6 weeks. A subset of mice undergoing exposure 
for 2 weeks was allowed to recover for an additional 2 and 
4 weeks (recovery/washout). The number of animals in each 
of the experimental groups are included in the text, figures, 
and tables.
Ototoxic exposure
IDPN exposure was based on a previously established pro-
tocol (Greguske et al. 2019) with minor adjustments to the 
exposure timeline. Briefly, mice were allowed 1 week to 
acclimatize after arrival. Mice were then randomly assigned 
to either the control or treatment groups. Mice selected for 
treatment were exposed to 30 mM IDPN in their drinking 
water (n = 44); control mice were given standard drinking 
water (n = 39). Water bottles were changed weekly and 
weighed to estimate the dose received.
Vestibular dysfunction rating
To assess peripheral vestibular function in IDPN-treated, 
control, and washout mice, three behaviors during an open 
field observation and three anti-gravity reflexes were scored 
as described previously in mice (Boadas-Vaello et al. 2007, 
2009; Greguske et al. 2019; Saldana-Ruiz et al. 2012, 2013; 
Soler-Martin et al. 2007) and rats (Boadas-Vaello et al. 2005; 
Llorens et al. 1993; Llorens and Rodriguez-Farre 1997; 
Sedó-Cabezón et al. 2015). During the open field observa-
tion, mice were placed in an empty rat cage and observed 
for 1 min in silence for head bobbing (intermittent extreme 
backward extension of the neck), circling (stereotyped circu-
latory ambulation), and retropulsion (backward movement). 
For the anti-gravity reflexes, mice were assessed using the 
tail-lift reflex, the air-righting reflex, and the contact-inhibi-
tion of the righting reflex. Scores for both types of tests were 
scaled from 0 (normal function) to 4 (highly dysfunctional); 
therefore, the total vestibular dysfunction rating (VDR) for 
the entire test battery ranged from 0 to 24.
Auditory brainstem response measurements
Mice were anesthetized with 75 mg/kg ketamine and 1 mg/
kg dexmedetomidine via subcutaneous injection into the 
loose skin between the shoulders and neck. After confirma-
tion of anesthesia, auditory brainstem responses (ABRs) 
were measured as described previously (Reijntjes et al. 
2019). Both click and pure tone (8, 16, 24, 32 kHz) ABRs 
were recorded from the right ear only to reduce the total 
time under anesthesia. Dedicated hardware and software 
were used to generate acoustic stimuli (Intelligent Hearing 
Systems). ABRs were recorded with an initial intensity of 
20 dB SPL and then increased to 90 dB SPL in 5 dB SPL 
increments. Electrode recordings were amplified 100X, 
bandpass filtered between 30 and 3000 Hz, and averaged 
over 512 recordings. ABR wave I absolute thresholds were 
set at the first intensity where the peak of wave I was dis-
tinguishable above the noise and appeared consistently in 
subsequent recordings. ABR wave I amplitudes were set 
by marking the peak of wave I and its preceding trough. 
ABR wave I latencies were calculated as the time delay for 
which the peak of wave I appeared after the click stimulus 
or tone burst was presented.
Isolation and immunofluorescence staining 
of the auditory and vestibular epithelia
For collection of auditory epithelia (organs of Corti) and 
vestibular epithelia, mice were euthanized by decapitation 
immediately following the final ABR measurements and 
while still under anesthesia. The bony labyrinths, which 
house the inner ear sensory epithelia, of both ears were 
wholly extracted from the temporal bones and prepared 
for immunofluorescence as described previously (McLean 
et al. 2009; Schuth et al. 2014). Small holes were chiseled 
into the bone above the utricle and in the apical end of the 
cochlea to allow penetration of ice-cold fixation solution, 
4% paraformaldehyde (PFA) in phosphate buffered saline 
(PBS), for 1 h. After fixation, the bony labyrinths were 
then placed into ice-cold PBS, and the cochlear and ves-
tibular sensory epithelia were carefully extracted. Tissue 
was stored in cold PBS until further processing.
Isolated sensory epithelia were dissected from the bony 
labyrinth and immediately placed into blocking buffer 
(PBS with 5% normal goat serum, 4% Triton X-100, and 
1% saponin) for at least 1 h and then incubated overnight 
with the primary antibodies diluted in blocking buffer. 
Two primary antibody combinations for the organs of 
Corti were used as follows: rabbit polyclonal anti-pres-
tin (gift from Dr. Mary Ann Cheatham; 1:3000), mouse 
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monoclonal (IgG1) anti-CTBP2/ribeye (BD Biosciences, 
612,044; 1:500), and mouse monoclonal (IgG2a) anti-
GluA2 (Millipore, MAP397; 1:300) or rabbit polyclonal 
anti-calretinin (Millipore, AB1550; 1/500) and mouse 
monoclonal (IgG1) anti-CASPR1 (NeuroMab, K65/35 or 
75-001; 1:300. Primary antibody combinations for the ves-
tibular sensory epithelia were as follows: rabbit polyclonal 
anti-MYO7A (Prestige Antibodies, HPA028918; 1:500), 
anti-CTBP2/ribeye (IgG1, 1:500), and anti-GluA2 (IgG2a, 
1:300) or anti-MYO7A (rabbit, 1:500), and anti-CASPR1 
(IgG1, 1:300). Samples were rinsed 3 times 10 min with 
PBS with 0.6% Triton-X 100 (PBT) and then incubated 
with the secondary antibodies for at least 4 h. The same 
secondary antibodies were used for all primary antibody 
combinations for both the organs of Corti and vestibular 
sensory epithelia: AlexaFluor 488 goat anti-mouse (IgG1, 
ThermoFisher, A-21121), AlexaFluor 568 goat anti-rabbit 
(IgG, ThermoFisher, A-11011), and AlexaFluor 647 goat 
anti-mouse (IgG2a, ThermoFisher, A-21241). All second-
ary antibodies used were diluted 1:500 in blocking buffer. 
All incubations and rinses were performed on a rocking 
platform at room temperature. Incubations with secondary 
antibodies were performed in the dark. Organs of Corti 
and vestibular sensory epithelia were mounted and stored 
at 4 °C.
Cochlear place‑frequency maps
To identify tonotopic regions in the organ of Corti, cochlear 
place-frequency maps were determined for each organ of 
Corti from each ear of each mouse. Briefly, low magnifica-
tion micrographs were obtained using a Leica DM4000b 
microscope with a 5X objective. A montaged image of indi-
vidual cochlear sections (generally 2–3 sections) was con-
structed for each organ of Corti using Fiji ImageJ. Tonotopic 
maps were overlaid using the mouse cochlear frequency map 
determined previously (Müller et al. 2005) in Fiji ImageJ 
(using a plugin found at: https ://www.masse yeand ear.org/
resea rch/otola ryngo logy/eaton -peabo dy-labor atori es/histo 
logy-core).
Confocal microscopy
Confocal image z-stacks of the organs of Corti and vestibu-
lar sensory epithelia were obtained using a Leica TCS SP8 
confocal microscope. Images were taken with the 63X oil 
immersion objective with a resolution of 1024X1024 pixels 
at a speed of 400 Hz. The z-step was optimized to 0.3 µm 
for all images. z-stacks ranged in thickness from 6 to 13 µm 
(for utricle) or 25–50 µm (for organs of Corti) to encompass 
the entire synaptic pole of the sensory HCs. For organs of 
Corti, image z-stacks were taken at the 8, 16, 24, and 32 kHz 
frequencies with an optical zoom of 1. For the utricle, image 
z-stacks were taken in the striola of the utricular macula with 
an optical zoom of 2.
Image analysis
The majority of quantitative image analysis was performed 
using Imaris v7.6. The number of cochlear IHCs was deter-
mined by CTBP2-immunolabeling of the IHC nuclei. The 
number of cochlear OHCs was determined by prestin-immu-
nolabeling of the OHC lateral walls. The number of ves-
tibular HCs was determined by MYO7A-immunolabeling 
in the striola (central region) of the utricular macula. To 
compare numbers across regions of interest (ROIs), IHC and 
OHC numbers were relative to a given length (100 µm) and 
the number of vestibular HCs were relative to a given area 
(100 µm2).
For both organs of Corti and vestibular sensory epithelia, 
CTBP2-labeled HC presynaptic ribbons and GluA2-labeled 
postsynaptic glutamate receptors were detected using the 
“spots” function. Colocalization of pre- and post-synaptic 
elements was determined using the integrated MatLab 
function “colocalize spots”. CTBP2-positive ribbons and 
GluA2-positive postsynapses were considered colocalized 
when they were within 1 µm of each other. All spots and 
colocalizations were visually confirmed. The number of syn-
aptic elements per HC was determined by dividing the total 
number of synaptic elements by the number of HCs in the 
ROI. In the organ of Corti, at least 10 IHCs were included 
for each analysis. In the striola of the utricular macula, all 
complete HCs within the ROI were analyzed.
To quantify CASPR1 immunoreactivity in the organs of 
Corti, the “measure” function was used to determine the 
lengths of the (first) CASPR1-labeled heminodes of type 
I SGN afferent terminals contacting the IHCs. At least six 
measurements were made per IHC, and at least six IHCs 
were analyzed per frequency region per organ of Corti (that 
is, per animal). To quantify the fraction of vestibular HCs 
contacted by CASPR1-labeled calyces in the striola of the 
utricular macula, the total number of MYO7A-labeled HCs 
was counted and divided by the total number of CASPR1-
labeled calyces in the same ROI.
Data analysis
All data were analyzed with the GraphPad Prism 8 program 
and presented as mean ± SEM. unless otherwise indicated. 
Data were analyzed by the appropriate one-way ANOVA 
models with multiple comparisons or mixed effects analy-
ses (Tukey’s or Dunnett’s method), or by unpaired t tests. 
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Statistical tests are provided in the text. Statistical signifi-
cance was identified when p values were less than 0.05. p 
values less than 0.0005 are reported as p ≪ 0.05.
Results
IDPN exposure causes progressive high to low 
frequency hearing loss
We assessed hearing loss in response to IDPN exposure 
using ABR measurements (Fig. 1). ABR wave I thresholds 
in response to click stimuli and pure tones (8, 16, 24, and 
32 kHz) were measured at baseline (0 weeks) and again after 
2, 4, and 6 weeks of exposure to IDPN (Fig. 1a; Table 1). 
Even at baseline, thresholds at 32 kHz were greater than 
80 dB SPL, consistent with previous reports of accelerated 
age-related hearing loss in this strain (Zheng et al. 1999). 
Statistically significant increases in thresholds were 
observed for click stimuli and all pure tones examined as 
early as 2 weeks after exposure, with greater threshold shifts 
observed for higher frequencies (24 kHz) than lower frequen-
cies (8 and 16 kHz). After 6 weeks of exposure, thresholds 
for click stimuli and all pure tones were greater than 80 dB 
SPL. To evaluate the effect of IDPN exposure, separate one-
way ANOVA analyses were conducted for click, 8, 16, and 
24 kHz data with duration of exposure (weeks) as the factor. 
In all cases, statistically significant differences were detected 
[F(3,114) = 388.5, F(3,114) = 101.2, F(3,114) = 453.9, 
F(3,114) = 83.9, respectively, all p ≪ 0.05].
In addition to ABR wave I absolute thresholds, we 
also examined the effects of IDPN exposure on wave I 
amplitude and latency input/output (I/O) slopes (Fig. 1b, 
c; Table 1). These slopes indicate the steepness by which 
Fig. 1  IDPN exposure causes progressive high to low frequency hear-
ing loss assessed by ABR measurements. a–c Mean absolute ABR 
wave I thresholds (a), wave I amplitude I/O slopes (b), and wave I 
latency I/O slopes (c) are shown across exposure durations for click 
stimuli and the indicated pure tone frequencies. Wave I thresholds 
increase progressively from high to low frequencies with increasing 
IDPN exposure. Wave I amplitudes decrease progressively from high 
to low frequencies with increasing IDPN exposure. Wave I latencies 
show no significant (ns) changes across frequencies in response to 
IDPN exposure. In all panels, letters indicate comparisons that are 
significantly different. Exposure durations are indicated as baseline 
(white bars), 2 weeks (light grey bars), 4 weeks (dark grey bars), and 
6 weeks (black bars). The numbers (n) of animals assessed are indi-
cated
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amplitudes increase and the latencies decrease simulta-
neously as a function of increasing stimulus intensities. 
ABR wave I absolute thresholds were greater than 80 dB 
SPL when measured in response to (1) 32 kHz pure tones 
at baseline, (2) 24 kHz pure tones after 2 weeks of IDPN 
exposure, and (3) click stimuli and all pure tones tested 
after 6 weeks of IDPN exposure. Therefore, I/O slopes 
were not calculated for these three conditions. For the 
remaining data, wave I amplitude I/O slopes showed sta-
tistically significant loss of steepness for click stimuli and 
8 and 16 kHz pure tones [F(2,102) = 17.4, F(2,105) = 45.4, 
F(2,101) = 25.4, respectively, all p ≪ 0.05]. There is sta-
tistically significant loss of steepness for click stimuli and 
8 and 16 kHz pure tones after 2 weeks of IDPN exposure 
(p = 0.037 for click and p ≪ 0.05 for both 8 and 16 kHz). 
For click stimuli and 8 kHz pure tones, steepness was 
further significantly reduced after an additional 2 weeks 
of IDPN exposure (that is, after 4 weeks of total expo-
sure; both p ≪ 0.05); the slope steepness for 16 kHz pure 
tones remained at a reduced state after 4 weeks of IDPN 
exposure (p ≪ 0.05, Fig.  1b). Statistically significant 
loss of steepness was observed for the 16 kHz pure tone 
[F(2,98) = 10.4, p ≪ 0.05] after 4 weeks of IDPN exposure 
only (Fig. 1c). In contrast, wave I latency I/O functions 
showed no statistically significant differences after either 
2 or 4 weeks of exposure to IDPN for click stimuli or the 
8 kHz pure tone.
To validate that the changes in auditory function observed 
in response to IDPN exposure were not confounded by age-
related hearing loss (Zheng et al. 1999), we also examined 
ABR wave I absolute thresholds as well as wave I amplitude 
and latency I/O functions at baseline (0 weeks) and again 
after 2, 4, and 6 weeks in control mice not exposed to IDPN 
(Supplemental Fig. 2 and Supplemental Table 2). No sig-
nificant differences in any of these measures were observed, 
indicating that age-related hearing loss is not contributing 
to the progressive, high- to low-frequency hearing loss 
observed in response to IDPN exposure.
IDPN exposure causes progressive 
loss of vestibular function that scales 
with hearing loss
To assess if the severity of hearing loss scaled with vestibu-
lar dysfunction, we quantified vestibular dysfunction (Fig. 2a 
and Table 2) and then examined the relationship between 
ABR wave I absolute threshold shifts for click stimuli and 
vestibular dysfunction (Fig. 2b; Table 2). As reported previ-
ously in a related strain of mice (Greguske et al. 2019) and in 
rats (Boadas-Vaello et al. 2005; Llorens et al. 1993; Llorens 
and Rodriguez-Farre 1997; Sedó-Cabezón et al. 2015), ves-
tibular dysfunction increased with increasing IDPN expo-
sure. Increasing vestibular dysfunction was observed in mice 
after 2, 4, and 6 weeks of IDPN exposure in comparison 
to control mice, which showed no vestibular dysfunction 
across the same time course. There was a positive correla-
tion between hearing loss (ABR wave I absolute threshold 
shifts) and vestibular dysfunction (Fig. 2b). The relationship 
was nonlinear and best fit with a single order exponential, 
indicating that, in response to IDPN exposure, auditory dys-
function (at least as assessed by ABR wave I thresholds) 
worsened more quickly than vestibular dysfunction (at least 
as assessed using observations of behavior and reflexes). 
IDPN exposure causes loss of cochlear outer 
but not inner hair cells
To determine the cochlear pathology underling the loss 
of auditory function, we examined isolated organs of 
Corti, from mice at baseline (0 weeks) and after 2, 4, or 
Table 1  Wave I ABR absolute thresholds and wave I amplitude and latency I/O slopes following IDPN exposure
Measure Treatment Click 8 kHz 16 kHz 24 kHz 32 kHz
Wave I absolute thresh-
olds (dB SPL)
Baseline (n = 77) 38.7 ± 0.5 42.5 ± 0.7 28.4 ± 0.5 62.4 ± 1.2 87.2 ± 0.7
IDPN (2 weeks, n = 14) 53.2 ± 1.9 51.1 ± 1.2 38.2 ± 1.8 88.9 ± 0.6 > 90
IDPN (4 weeks, n = 18) 78.1 ± 2.2 64.4 ± 2.6 77.2 ± 2.7 > 90 > 90
IDPN (6 weeks, n = 9) 89.4 ± 0.6 83.3 ± 4.4 87.2 ± 1.5 > 90 > 90
Wave I amplitude I/O 
slopes (µV/dB SPL)
Baseline (n = 77) 0.096 ± 0.003 0.069 ± 0.002 0.065 ± 0.002 – –
IDPN (2 weeks, n = 14) 0.080 ± 0.006 0.045 ± 0.006 0.037 ± 0.004 – –
IDPN (4 weeks, 
n = 13–17)
0.058 ± 0.007 (n = 14) 0.022 ± 0.003 (n = 17) 0.039 ± 0.005 (n = 13) – –
Wave I latency I/O 
slopes (µs/dB SPL)
Baseline (n = 77) −6.53 ± 0.14 −10.86 ± 0.22 −9.00 ± 0.13 – –
IDPN (2 weeks, n = 14) −6.96 ± 0.43 −11.79 ± 0.55 −8.86 ± 0.30 – –
IDPN (4 weeks, 
n = 10–16)
−5.85 ± 1.08 (n = 14) −10.09 ± 0.57 (n = 16) −11.71 ± 1.52 (n = 10) – –
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6 weeks of exposure to IDPN (Fig. 3). Epithelia were 
immunostained with anti-prestin to detect OHCs and 
anti-CTBP2 to detect IHCs (more specifically, the IHC 
nuclei) and examined at four different frequency regions 
(8, 16, 24, and 32 kHz). Epithelia isolated from control 
mice showed the expected pattern of three rows of OHCs 
and a single row of IHCs, with no missing HCs in any of 
the frequency regions examined. After 2 weeks of IDPN 
exposure, OHCs and IHCs were intact. However, after 
4 weeks of IDPN exposure, OHCs were missing from the 
higher frequency regions (24 and 32 kHz), whereas IHCs 
appeared intact. Finally, after 6 weeks of IDPN exposure, 
OHCs were either entirely absent or missing from most 
frequency regions, whereas IHCs remained intact.
Both inner and outer hair cell loss was quantified across 
tonotopic regions (Fig. 4; Table 3). Within a given frequency 
region, there was no significant difference in the number of 
IHCs between control mice or mice exposed to IDPN for 2, 4, 
or 6 weeks (Fig. 4a). In contrast, one-way ANOVA indicated 
significant differences across time of exposure in OHC counts 
at the different frequencies [16, 24, 32 kHz; F(3,27) = 24.0, 
F(3,23) = 33.1, F(3,25) = 227.8, respectively, all p ≪ 0.05]. 
After 4 weeks of IDPN exposure, there was significant loss 
of OHCs by 36% and 77% in the respective 24 and 32 kHz 
regions (Fig. 4b). After 6 weeks, there was significant loss of 
OHCs by 70%, 86%, and 98% in the respective 16, 24, and 
32 kHz regions (Fig. 4b). Thus, IDPN exposure causes pro-
gressive loss of OHCs from high to low frequency regions 
of the cochlea, whereas no loss of IHCs was observed in any 
cochlear region for up to 6 weeks of IDPN exposure.
IDPN exposure causes loss of both cochlear 
and vestibular afferent synapses
Loss of OHCs (Figs. 3, 4) is consistent with elevated ABR 
wave I absolute thresholds also observed in response to 
IDPN exposure (Fig.  1). However, elevated absolute 
Fig. 2  IDPN exposure causes progressive loss of vestibular function 
that scales with hearing loss. a Vestibular dysfunction (assessed by 
rating behavior and reflexes) is shown as a function of IDPN exposure 
and indicates worsening vestibular function with increasing IDPN 
exposure. b Auditory dysfunction (assessed by shifts in the ABR 
wave I thresholds to click stimuli) is shown as a function of vestibular 
dysfunction and is best fit with a single order exponential, indicating 
that auditory dysfunction worsened more quickly compared to ves-
tibular dysfunction following IDPN exposure. In both panels, expo-
sure durations include baseline (white circles), 2  weeks (light grey 
circles), 4 weeks (dark grey circles), and 6 weeks (black circles). The 
numbers (n) of animals assessed are indicated
Table 2  Vestibular dysfunction ratings (VDRs) and wave I ABR 
absolute threshold shifts following IDPN exposure
a VDRs for control mice at 0 (n = 83), 2 (n = 14), 4 (n = 25), and 6 
(n = 19) weeks were always equal to 0
Treatment VDR Wave I ABR absolute 
threshold shift (dB SPL)
Control (Baseline, 2, 4, 
6 weeks, n = 14–83)a
0 ± 0 0 ± 0
IDPN (2 weeks, n = 14) 1.4 ± 0.2 15 ± 2.0
IDPN (4 weeks, n = 18–24) 5.3 ± 0.4 38.1 ± 2.5
IDPN (6 weeks, n = 9–12) 13.5 ± 1.2 50.6 ± 1.0
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thresholds were observed as early as 2 weeks after IDPN 
exposure, when no OHC loss was yet detected. For this 
reason, we suspected that cochlear synaptopathy—loss of 
synapses between the IHCs and the type I SGN afferent 
terminals—might also occur in response to IDPN exposure 
(Fig. 5). To identify synapses, we immunostained organs 
Fig. 3  IDPN exposure causes progressive damage to the sensorineu-
ral structures of the organ of Corti. Z-projections through the organs 
of Corti immunostained with anti-CTBP2 to detect IHC nuclei and 
presynaptic ribbons (green) and anti-prestin (red) to detect OHCs 
are shown at four tonotopic regions (corresponding to 8, 16, 24, 
and 32 kHz) at the indicated exposure durations (baseline, 2 weeks, 
4 weeks, and 6 weeks). Increasing IDPN exposure causes progressive 
loss of the OHCs and presynaptic ribbons from high to low frequency 
regions. Scale bar equals 25 µm (color figure online)
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of Corti isolated from control mice and mice exposed to 
IDPN after 2, 4, or 6 weeks. Epithelia were immunostained 
with anti-CTBP2 to detect presynaptic ribbons and anti-
GluA2 to detect postsynaptic glutamate receptors, and 
examined at four different frequency regions (8, 16, 24, 
and 32 kHz). At baseline (0 weeks, Fig. 5a), CTBP2-
labeled presynaptic ribbons were colocalized with GluA2-
labeled postsynapses (upper panels and ROIs in lower pan-
els). In contrast, after 6 weeks of IDPN exposure (Fig. 5b), 
the numbers of CTBP2-labeled presynaptic ribbons and 
GluA2-labeled postsynapses were reduced (upper panel) 
and synaptic elements were not always colocalized (lower 
panels from indicated region of interest).
Synapse loss was quantified across four tonotopic 
regions for control mice and mice exposed to IDPN for 
2, 4, and 6 weeks (Fig. 5c–e; Table 4). Within a given fre-
quency region, there was no significant difference in the 
number of CTBP2 (Fig. 5c), GluA2 (Fig. 5d), or paired 
CTBP2-GluA2 (Fig. 5e) puncta per IHC present for con-
trols or after 2 weeks of IDPN exposure. In contrast, 
after 4 and 6 weeks of IDPN exposure, there was sig-
nificant loss of CTBP2 [16 kHz: F(3,37) = 19.6, 24 kHz: 
Fig. 4  IDPN exposure causes loss of cochlear OHCs. a–b The num-
bers of IHCs (a) and OHCs (b) are shown at four tonotopic regions 
(corresponding to 8, 16, 24, and 32 kHz) across exposure durations. 
IHC numbers show no significant (ns) changes across frequency 
regions in response to IDPN exposure. In contrast, OHC numbers 
are progressively reduced from high to low frequency regions with 
increasing IDPN exposure. Asterisks indicate comparisons that are 
significantly different. Exposure durations include baseline (white cir-
cles), 2  weeks (light grey circles), 4  weeks (dark grey circles), and 
6 weeks (black circles). The numbers (n) of animals assessed are indi-
cated
Table 3  Inner and outer hair cell counts following IDPN exposure
Hair cells Treatment 8 kHz 16 kHz 24 kHz 32 kHz
IHCs (per 100 µm) Control (2, 4, and 
6 weeks, n = 13–15)
12.7 ± 0.2 (n = 150 
IHCs)
12.6 ± 0.2 (n = 140 
IHCs)
12.8 ± 0.2 (n = 130 
IHCs)




12.8 ± 0.3 (n = 60 
IHCs)
13.0 ± 0.2 (n = 70 
IHCs)
12.0 ± 0.1 (n = 60 
IHCs)
12.0 ± 0.4 (n = 50 IHCs)
IDPN (4 weeks, n = 5) 12.5 ± 0.3 (n = 60 
IHCs)
13.1 ± 0.6 (n = 60 
IHCs)
13.3 ± 0.4 (n = 50 
IHCs)
13.1 ± 0.2 (n = 50 IHCs)
IDPN (6 weeks, n = 5) 12.3 ± 0.2 (n = 50 
IHCs)
12.4 ± 0.7 (n = 50 
IHCs)
11.7 ± 0.6 (n = 50 
IHCs)
12.6 ± 0.1 (n = 50 IHCs)
OHCs (per 100 µm) Control (2, 4, and 
6 weeks, n = 12–14)
37.3 ± 1.2 (n = 431 
OHCs)
39.2 ± 0.6 (n = 417 
OHCs)
37.3 ± 0.8 (n = 384 
OHCs)




38.1 ± 1.8 (n = 177 
OHCs)
38.5 ± 1.2 (n = 204 
OHCs)
37.8 ± 0.5 (n = 174 
OHCs)




38.4 ± 0.7 (n = 172 
OHCs)
37.3 ± 2.7 (n = 166 
OHCs)
24.1 ± 5.2 (n = 93 
OHCs)
8.6 ± 2.0 (n = 35 OHCs)
IDPN (6 weeks, n = 5) 32.2 ± 2.7 (n = 126 
OHCs)
11.7 ± 6.4 (n = 47 
OHCs)
5.2 ± 4.1 (n = 21 
OHCs)
0.9 ± 0.9 (n = 4 OHCs)
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F(3,40) = 13.3, 32 kHz: F(3,40) = 44.2, all p ≪ 0.05], 
GluA2 [16 kHz: F(3,37) = 24.4, 24 kHz: F(3,40) = 12.4, 
32 kHz: F(3,40) = 47.0, all p ≪ 0.05], and paired CTBP2-
GluA2 [16 kHz: F(3,37) = 20.2, 24 kHz: F(3,40) = 11.5, 
32 kHz: F(3,40) = 46.4, all p ≪ 0.05] puncta per IHC in 
all but the lowest frequency region (8 kHz) examined. 
Specifically, in the 16 kHz region, there was a significant 
reduction by 50% of paired CTBP2-GluA2 puncta per 
IHC after 6 weeks of IDPN exposure (p ≪ 0.05). In the 
24 kHz region, there was a significant reduction by 56% 
of paired CTBP2-GluA2 puncta per IHC after 6 weeks 
of IDPN exposure (p ≪ 0.05). Finally, in the highest 
Fig. 5  IDPN exposure causes loss of cochlear afferent synapses. 
a, b Z-projections through the organs of Corti immunostained with 
anti-CTBP2 to detect IHC nuclei and presynaptic ribbons (green) 
and anti-GluA2 to detect postsynaptic glutamate receptors (red) 
are shown at baseline (a) and after 6  weeks of IDPN exposure (b). 
Regions of interest are outlined in boxes in the upper panels and 
shown magnified in the corresponding lower panels. Scale bars equal 
15 µm in the upper panels and 10 µm in the lower panels. c–e The 
number of presynaptic elements (CTBP2 puncta per IHC, c), post-
synaptic elements (GluA2 puncta per IHC, d), and paired synaptic 
elements (paired puncta per IHC, e) are quantified at four tonotopic 
regions (corresponding to 8, 16, 24, and 32  kHz) at the indicated 
exposure durations (baseline, 2 weeks, 4 weeks, and 6 weeks). Syn-
aptic elements show no significant (ns) changes at the 8 kHz region. 
Above 8 kHz, however, synaptic elements are progressively reduced 
from high to low (but greater than 8  kHz) frequency regions with 
increasing IDPN exposure. In all panels, asterisks indicate compari-
sons that are significantly different. Exposure durations include base-
line (white circles), 2 weeks (light grey circles), 4 weeks (dark grey 
circles), and 6  weeks (black circles). The numbers (n) of animals 
assessed are indicated (color figure online)
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frequency region examined, 32 kHz, there was a signifi-
cant reduction by 58% and 68% of paired CTBP2-GluA2 
puncta per IHC after 4 and 6 weeks, respectively, of IDPN 
exposure (both p ≪ 0.05).
Loss of vestibular afferent synapses has also been 
reported in additional vestibular sensory epithelia (cris-
tae) of mice (Greguske et  al. 2019) and rats (Sedó-
Cabezón et  al. 2015) after chronic IDPN exposure. 
Therefore, we also quantified afferent synapse loss in the 
vestibular (utricular) sensory epithelium (Fig. 6; Table 5). 
To identify synapses, we immunostained epithelia from 
control mice (at 6 weeks) and after 6 weeks of expo-
sure to IDPN (Fig. 6a). To identify synaptic elements per 
HC, utricular epithelia were immunostained with anti-
CTBP2 to detect presynaptic afferent ribbons, anti-GluA2 
to detect glutamatergic postsynapses, and anti-MYO7A, 
a marker of both type I and type II HCs (Hasson et al. 
1997). In the striolar region, we found that IDPN expo-
sure had no effect on the numbers of MYO7A-positive 
HCs (Fig. 6b). In contrast, the number of CTBP2-posi-
tive presynaptic ribbons, GluA2-positive postsynapses, 
and paired synaptic elements per HC were significantly 
reduced after 6 weeks of IDPN exposure (unpaired t test, 
p ≪ 0.05, p = 0.036, p = 0.001, respectively, Fig. 6c). 
IDPN exposure causes loss of CASPR1 
from the calyx‑shaped afferent terminals 
of the vestibular neurons, but not from the 
paranodal region of the type I SGN afferent 
terminals
After 2 weeks of IDPN exposure, mice showed elevated 
ABR wave I absolute thresholds, but examination of coch-
lear afferent synapses revealed no synaptopathy (Fig. 5) or 
outer hair cell loss (Fig. 3). Thus, we further examined the 
molecular architecture of the type I SGN afferent terminals 
to identify the pathology contributing to early hearing loss 
after IDPN exposure. In the vestibular sensory epithelia, 
CASPR1 is enriched in the calyx-shaped afferent terminals 
contacting the type I HCs (Sousa et al. 2009). Previous work 
has shown that dismantlement of the calyceal junction, as 
evidenced by loss of CASPR1 immunoreactivity, is an early 
event in the afferent damage induced by IDPN exposure 
(Greguske et al. 2019; Sedo-Cabezón et al. 2015). In the 
type I SGN afferent terminals of the cochlea, CASPR1 is 
found at the first heminodes and subsequent paranodes (Hos-
sain et al. 2005), where it anchors and organizes ion channels 
essential for action potential generation.
Table 4  Synaptic elements per inner hair cell following IDPN exposure
Measure Treatment 8 kHz 16 kHz 24 kHz 32 kHz
CTBP2/IHC Control (Baseline, 2, 4, 
and 6 weeks, n = 21)
12.4 ± 0.3 (n = 458 
IHCs)
17.7 ± 0.4 (n = 444 
IHCs)
16.9 ± 0.4 (n = 411 
IHCs)




12.4 ± 0.5 (n = 108 
IHCs)
17.7 ± 0.2 (n = 152 
IHCs)
17.9 ± 0.9 (n = 122 
IHCs)




13.5 ± 0.6 (n = 157 
IHCs)
17.0 ± 0.4 (n = 176 
IHCs)
14.1 ± 1.5 (n = 220 
IHCs)
8.2 ± 1.4 (n = 228 IHCs)
IDPN (6 weeks, 
n = 5–6)
12.3 ± 0.3 (n = 145 
IHCs)
9.5 ± 2.3 (n = 100 
IHCs)
7.7 ± 2.1 (n = 131 
IHCs)
6.2 ± 1.3 (n = 139 IHCs)
GluA2/IHC Control (Baseline, 2, 4, 
and 6 weeks, n = 21)
11.7 ± 0.3 (n = 458 
IHCs)
17.0 ± 0.5 (n = 444 
IHCs)
16.1 ± 0.5 (n = 411 
IHCs)




13.0 ± 0.6 (n = 108 
IHCs)
18.2 ± 0.2 (n = 152 
IHCs)
18.1 ± 0.9 (n = 122 
IHCs)




11.9 ± 0.7 (n = 157 
IHCs)
15.5 ± 0.7 (n = 176 
IHCs)
13.0 ± 1.4 (n = 220 
IHCs)
8.1 ± 1.1 (n = 228 IHCs)
IDPN (6 weeks, 
n = 5–6)
11.1 ± 0.4 (n = 145 
IHCs)
8.6 ± 1.6 (n = 100 
IHCs)
8.5 ± 1.9 (n = 131 
IHCs)
6.8 ± 0.9 (n = 139 IHCs)
Paired puncta/IHC Control (Baseline, 2, 4, 
and 6 weeks, n = 21)
11.8 ± 0.4 (n = 458 
IHCs)
17.3 ± 0.4 (n = 444 
IHCs)
16.4 ± 0.5 (n = 411 
IHCs)




12.1 ± 0.6 (n = 108 
IHCs)
17.7 ± 0.2 (n = 152 
IHCs)
17.7 ± 0.9 (n = 122 
IHCs)




12.8 ± 0.7 (n = 157 
IHCs)
16.6 ± 0.6 (n = 176 
IHCs)
13.5 ± 1.8 (n = 220 
IHCs)
7.1 ± 1.5 (n = 228 IHCs)
IDPN (6 weeks, 
n = 5–6)
11.8 ± 0.4 (n = 145 
IHCs)
8.7 ± 2.3 (n = 100 
IHCs)
7.1 ± 2.2 (n = 131 
IHCs)
5.4 ± 1.2 (n = 139 IHCs)
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To investigate whether IDPN exposure causes a simi-
lar loss of CASPR1 in type I SGN afferent terminals, we 
immunostained organs of Corti isolated from control mice 
(6 weeks) and after 6 weeks of exposure to IDPN with 
anti-calretinin to label IHCs and the type I SGN afferent 
terminals and anti-CASPR1 (Fig. 7a). No qualitative dif-
ference in CASPR1 immunoreactivity was seen following 
IDPN exposure for either 4 (data not shown) or 6 weeks 
in comparison to control mice (Fig. 7a). To examine the 
distribution of CASPR1 more carefully, we quantified the 
length of CASPR1 distribution in at least 6 afferent termi-
nals per IHC and at least 6 IHCs per animal across 4 fre-
quency regions (Fig. 7c; Table 6). No significant differences 
(unpaired t tests) in distribution were observed.
In contrast to our findings in the organs of Corti, but con-
sistent with previous observations (Greguske et al. 2019; 
Sedó-Cabezón et al. 2015), parallel examination revealed 
complete loss of CASPR1 immunoreactivity in the striola of 
the utricular macula in response to IDPN exposure (Fig. 7b). 
In these experiments, vestibular sensory epithelia were iso-
lated from control mice (at 6 weeks) and after 6 weeks of 
exposure to IDPN and immunostained with anti-MYO7A 
to label vestibular hair cells and anti-CASPR1 (Fig. 7b). 
Quantification revealed no loss of MYO7A-positive HCs in 
Fig. 6  IDPN exposure causes 
loss of vestibular afferent syn-
apses. a Z-projections through 
the utricular sensory epithelia 
immunostained with anti-
CTBP2 to detect IHC nuclei 
and presynaptic ribbons (green), 
anti-GluA2 to detect postsyn-
aptic glutamate receptors (red), 
and Myo7A to detect HCs 
(blue) are shown at baseline and 
after 6 weeks of IDPN expo-
sure. Scale bar equals 15 µm. 
b The number of vestibular 
HCs is quantified at baseline 
(white bars) and after 6 weeks 
of IDPN exposure (black bars). 
There are no significant (ns) 
differences. c The number of 
presynaptic elements (CTBP2 
puncta per HC), postsynaptic 
elements (GluA2 puncta per 
HC), and paired synaptic ele-
ments (paired puncta per HC) 
are quantified at baseline (white 
bars) and after 6 weeks of IDPN 
exposure (black bars) and show 
significant reductions following 
IDPN exposure (indicated by 
asterisks) (color figure online)
Table 5  Synaptic elements per vestibular hair cell following IDPN 
exposure
Measure Treatment Striolar region
CTBP2/HC Control (6 weeks, 
n = 5)
13.5 ± 1.2 (n = 745 HCs)
IDPN (6 weeks, n = 6) 5.8 ± 0.5 (n = 807 HCs)
GluA2/HC Control (6 weeks, 
n = 4)
9.2 ± 1.2 (n = 745 HCs)
IDPN (6 weeks, n = 6) 6.2 ± 0.6 (n = 807 HCs)
Paired puncta/HC Control (6 weeks, 
n = 4)
11.5 ± 1.0 (n = 745 HCs)
IDPN (6 weeks, n = 6) 6.1 ± 0.5 (n = 807 HCs)
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Fig. 7  IDPN exposure causes loss of CASPR1 from the calyx-shaped 
afferent terminals of the vestibular neurons but not from the paran-
odal region of the type I SGN afferent terminals. a Z-projections 
through the organs of Corti immunostained with anti-CASPR1 
(green) and anti-calretinin to detect IHCs (red) are shown at baseline 
(left panel) and after 6 weeks of IDPN exposure (right panel). Scale 
bar equals 15 µm. b Z-projections through the utricular sensory epi-
thelia immunostained with anti-CASPR1 (green) and anti-Myo7A to 
detect HCs (red) are shown at baseline (left panel) and after 6 weeks 
of IDPN exposure (right panel). Scale bar equals 15 µm. c The distri-
bution of CASPR1 in the cochlear heminodes (length) is quantified 
at four tonotopic regions (corresponding to 8, 16, 24, and 32 kHz) at 
baseline (white circles) and after 6 weeks of IDPN exposure (black 
circles). There were no significant (ns) differences in CASPR1 dis-
trbution. d The number of CASPR1-positive calyces is quantified 
in control (white bars) and IDPN-exposed (black bars) animals at 
6  weeks and show significant reductions following IDPN exposure 
(indicated by asterisks) (color figure online)
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response to IDPN exposure (see Fig. 6b), but a dramatic 
reduction in the percentage of vestibular HCs associated 
with CASPR1-positive calyces after 6 weeks of IDPN expo-
sure (1.1 ± 0.6%) compared to control (69.6 ± 2.4%, Fig. 7d) 
was observed (unpaired t test, p ≪ 0.05). These experiments 
show that loss of CASPR1 in response to IDPN exposure is 
specific to the calyceal junctions of the vestibular sensory 
epithelia and not observed in the paranodal regions of the 
type I SGN afferent dendrites in the organ of Corti.
Auditory function recovers 
following cessation of short‑duration IDPN 
exposure
The lack of observable structural pathology after 2 weeks 
of IDPN exposure led us to speculate that elevated ABR 
wave I absolute thresholds observed after 2 weeks of IDPN 
exposure may recover to baseline values following cessation 
of IDPN exposure. To test this hypothesis, we exposed mice 
to IDPN for 2 weeks and then allowed either 2 or 4 weeks 
of recovery (Fig. 8; Table 7). In comparison to baseline 
values (0 weeks), wave I ABR thresholds were signifi-
cantly elevated for click stimuli and pure tones (8, 16, and 
24 kHz) after 2 weeks of IDPN exposure (Fig. 8a). Wave 
I ABR amplitude I/O slopes were also decreased for click 
stimuli (Fig. 8b) and for pure tones of 8 (Fig. 8c) and 16 kHz 
(Fig. 8d). Data from baseline (0 weeks) and IDPN (2 weeks) 
are re-plotted from Fig. 1 to only include the animals tracked 
in the recovery experiments. Because ABR wave I amplitude 
responses were greater than 80 dB SPL when measured in 
response to 24 and 32 kHz pure tones after 2 weeks of IDPN 
exposure, ABR wave I amplitude I/O slopes were not calcu-
lated for these frequencies. Because ABR wave I latency I/O 
slopes did not show significant differences after 2 weeks of 
exposure (Fig. 1c) these values were not calculated for the 
recovery experiments.
After 4 weeks of recovery from IDPN exposure, ABR 
wave I absolute thresholds for click stimuli and 8 and 16 kHz 
pure tones recovered to baseline values [F(3,50) = 22.5, 
F(3,50) = 11.1, F(3,50) = 12.8, respectively, all p ≪ 0.05], but 
not for 24 kHz pure tones. ABR wave I amplitude I/O slopes 
were also not significantly different between values meas-
ured at baseline and after 4 weeks of recovery (Fig. 8b–d). 
After 2 weeks of IDPN intoxication, ABR wave I amplitude 
I/O slopes were significantly reduced for the click stimuli 
and the 8 and 16 kHz pure tones compared to baseline 
[F(1.438,10.07) = 25.4, p = 0.02, F(1.337,9.359) = 18.8, 
p = 0.008, F(1.613,9.678) = 54.7, p ≪ 0.05, respectively, 
Fig. 8b–d]. Surprisingly, after 2 weeks of recovery, ABR 
wave I absolute thresholds were not fully recovered and, 
in fact, ABR wave I amplitude I/O slopes remained signifi-
cantly reduced in comparison to baseline values for click 
stimuli and 8 and 16 kHz pure tones (p = 0.003, p = 0.005, 
p = 0.005, respectively, Fig. 8b–d).Together, these data show 
that after cessation of IDPN exposure—at least at exposure 
durations that are not associated with structural pathology—
wave I ABR responses continue to worsen but ultimately 
recover to baseline values.
Discussion
In this study, we characterized the effects of chronic admin-
istration of IDPN (at doses known to cause peripheral ves-
tibular ototoxicity) on the cochlea, the auditory end organ. 
Cochlear pathology was quantified using ABR measure-
ments and immunohistological assessments of the IHCs 
and OHCs and the synapses between the IHCs and type I 
SGNs. Functionally, chronic IDPN exposure caused audi-
tory thresholds that progressively worsened from high to 
low frequencies. Morphologically, chronic IDPN exposure 
caused outer but not inner HC loss that also progressed from 
high to low frequency regions of the cochlea. The number 
of synapses between the IHCs and type I SGNs was also 
reduced at higher frequencies with chronic IDPN exposure. 
With continued exposure, structural pathology manifested 
as parallel loss of OHCs and loss of synapses between the 
IHCs and type I SGNs. Importantly, auditory thresholds 
were reduced before evidence of structural pathology, and 
auditory thresholds recovered fully if IDPN administration 
was stopped before evidence of structural pathology.
These findings are consistent with previous characteriza-
tion of the cochlear pathology in response to IDPN exposure 
in rats and guinea pigs. Previous work in rats exposed sub-
acutely to IDPN showed that dysfunction is dose-dependent, 
occurs first in high frequency regions of the cochlea (exam-
ined using reflex modification audiometry: Crofton and 
Knight 1991), and, with sufficiently high doses, occurs in 
both high and low frequency regions of the cochlea (exam-
ined using ABR to filtered click stimuli: Crofton et al. 1994). 
Moreover, and consistent with our findings, examination of 
Table 6  Quantification of CASPR1 expression in the organ of Corti following IDPN exposure
Measure Treatment 8 kHz 16 kHz 24 kHz 32 kHz
CASPR1 Length (µm) in cochlear type I afferents Control (6 weeks, n = 5–6) 3.4 ± 0.1 3.5 ± 0.1 3.8 ± 0.1 3.4 ± 0.2
IDPN (6 weeks, n = 5) 3.6 ± 0.04 3.7 ± 0.1 3.8 ± 0.1 3.5 ± 0.2
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suprathreshold ABRs revealed decreased wave I amplitudes 
but no statistically significant differences in wave I latencies 
(Crofton et al. 1994). In contrast to our findings, previous 
examination of IDPN-exposed rats revealed that the highest 
dosages were associated with pathology throughout the 
cochlea, including not only the organ of Corti but also the 
stria vascularis, the SGNs, and the cochlear nerve (Crofton 
et al. 1994). We did not examine the morphology of the stria 
Fig. 8  IDPN exposure followed by recovery causes hearing loss fol-
lowed by recovery assessed by ABR measurements. a–c Mean abso-
lute ABR wave I thresholds (a) and wave I amplitude I/O slopes 
(b–d) are shown across exposure/recovery durations for click stimuli 
and the indicated pure tone frequencies. Wave I thresholds increase 
with IDPN exposure and then recover to pre-exposure values after 
4  weeks of recovery. Wave I amplitudes decrease with IDPN expo-
sure and recover to pre-exposure values after 4 weeks of recovery. In 
all panels, asterisks indicate significant differences and ns indicates 
non-significant differences. Exposure/recovery durations are indicated 
as baseline (white bars), 2  weeks of IDPN exposure (black bars), 
2 weeks of recovery (dark grey bars), and 4 weeks of recovery (light 
grey bars). The numbers (n) of animals assessed are indicated
Table 7  Wave I ABR absolute thresholds and wave I amplitude I/O slopes following IDPN exposure and subsequent recovery





Baseline (n = 29) 37.9 ± 1.0 41.6 ± 1.0 27.1 ± 0.6 59.3 ± 1.9 85.3 ± 1.4
IDPN (2 weeks, n = 14) 53.2 ± 1.9 51.1 ± 1.2 38.2 ± 1.8 88.9 ± 0.6 > 90
Recovery (+ 2 weeks, n = 6) 46.7 ± 2.1 46.7 ± 3.1 37.5 ± 5.6 88.3 ± 1.1 > 90





Baseline (n = 13–14) 0.097 ± 0.005 (n = 14) 0.068 ± 0.005 (n = 14) 0.066 ± 0.003 (n = 13) – –
IDPN (2 weeks, n = 13–14) 0.080 ± 0.006 (n = 14) 0.045 ± 0.006 (n = 14) 0.038 ± 0.004 (n = 13) – –
Recovery (+ 2 weeks, n = 4–5) 0.028 ± 0.003 (n = 5) 0.024 ± 0.005 (n = 5) 0.022 ± 0.003 (n = 4) – –
Recovery (+ 4 weeks, n = 4–5) 0.081 ± 0.008 (n = 5) 0.078 ± 0.007 (n = 5) 0.076 ± 0.004
(n = 4)
– –
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vascularis, the SGNs, or the cochlear nerve in these experi-
ments but suspect that pathology of these structures would 
only be apparent at extended doses under our administration 
regime.
Importantly, our work is unique in identifying the ear-
liest stages of cochlear pathology in response to chronic 
IDPN exposure and, thereby, establish a model to identify 
the mechanisms responsible for the earliest and likely most 
reversible stages of hearing loss during chronic ototoxicity. 
First, we specifically examined the integrity of the afferent 
synapses between the IHCs and type I SGN afferent den-
drites. These synapses have received increasing attention 
as the cochlear structures most vulnerable to noise-induced 
and age-related loss (Liberman and Kujawa 2017). In our 
experiments, loss of afferent synapses and OHCs in response 
to IDPN exposure occurred with a similar spatial (tonotopic) 
and temporal progression and was associated with functional 
loss, as revealed by ABR data, in absence of significant IHC 
loss. A parallel loss of OHCs and type I SGN afferent ter-
minals largely exceeding IHC loss has also been previously 
reported in an acute gentamicin model, but these authors 
did not examine auditory function and did not associate the 
pathological changes to frequency regions of the cochlea 
(Ruan et al. 2014). While the greater susceptibility of OHCs 
compared to IHCs to ototoxic insults is well established, 
the co-occurrence of cochlear synaptopathy has not been 
previously identified. Our findings together with previous 
findings from mice (Ruan et al. 2014) and humans (Hinojosa 
and Lerner 1987; Sone et al. 1998) support the conclusion 
that cochlear synaptopathy has a significant role in ototoxic-
induced hearing loss. Additional work is necessary to estab-
lish whether the auditory synapses are more vulnerable than 
OHCs to exposure to IDPN and other ototoxic compounds, 
particularly in chronic exposure paradigms. As discussed 
below, the recovery data in the present work support this 
prediction.
In this work, we also compared the physiological, 
behavioral, and morphological pathology between the 
auditory and vestibular end organs in IDPN-exposed 
mice. There were notable similarities and differences in 
the functional, morphological, and molecular pathology in 
response to IDPN exposure between these two structures. 
Functionally, auditory dysfunction assessed by ABR was 
correlated to vestibular dysfunction assessed behaviorally; 
however, auditory dysfunction was detected before ves-
tibular dysfunction could be detected and also progressed 
more rapidly. These findings suggest that sensorineural 
structures in the cochlea may be more vulnerable to IDPN 
exposure in comparison to sensorineural structures in the 
vestibule. This difference in vulnerability may be influ-
enced by differences in the innate regenerative capacity of 
these structures. Even in response to persistent end organ 
damage, vestibular function shows some recovery (Cassel 
et al. 2019), and regeneration of HCs following IDPN 
exposure has been specifically reported (Sayyid et  al. 
2019). In contrast, equivalent regeneration and recovery 
of sensorineural structures has not been reported in the 
cochlea. Thus, the reduced regenerative capacity of the 
cochlea in comparison to the vestibule may contribute to 
the greater vulnerability of the cochlea in comparison to 
the vestibule in response to IDPN exposure. Further work 
is necessary to substantiate this hypothesis.
Morphologically, in both the cochlea and vestibule, we 
observed loss of afferent synapses. However, we observed 
extensive loss of cochlear HCs, specifically OHCs, but no 
loss of vestibular HCs. Vestibular HC loss has been reported 
previously in mice and other species using different IDPN 
administration schemes, including chronic drinking water 
exposure (Greguske et al. 2019; Llorens et al. 1993; Llorens 
and Rodriguez-Farre 1997; Soler-Martin et al. 2007). Thus, 
vestibular HC loss would have been observed had IDPN 
been administered at higher doses and/or longer durations 
in these experiments. Nevertheless, sparing of vestibular but 
not cochlear HCs supports the hypothesis of increased coch-
lear sensitivity to IDPN exposure, at least in this species and 
administration regime.
Molecularly, we observed no change in the expression or 
distribution of CASPR1, a key component of mammalian 
paranodal junctions (Einheber et al. 1997), in type I SGN 
afferent terminals in the cochlea in response to IDPN expo-
sure. In contrast, this and previous (Greguske et al. 2019; 
Sedó-Cabezón et al. 2015) work showed complete loss of 
CASPR1 in the calyx-shaped afferent terminals contact-
ing the type I HCs in the vestibule in response to IDPN 
exposure. Even under the IDPN administration regime used 
in this study, where no loss of vestibular HCs occurred, 
CASPR1 immunoreactivity was nevertheless completely 
abolished. We suspect the different pathologies reflect dif-
ferent functions served by CASPR1 in these two structures: 
organization of action potential initiation zones in the type I 
SGN afferent terminals in the cochlea versus synaptic adhe-
sion in the calyceal junctions in the vestibule. In support of 
this speculation, paranodal CASPR1 is maintained in the 
vestibular afferent axons despite loss of CASPR1 in the cal-
yceal junctions of the same afferents in response to IDPN 
exposure (unpublished findings).
By characterizing the earliest stages of IDPN-induced 
chronic cochlear toxicity, we found that cochlear dysfunc-
tion evidenced by elevated auditory thresholds was detected 
before morphological (i.e., loss of outer hair cells and audi-
tory synapses) or molecular pathology (i.e. loss of CASPR1 
immunoreactivity) was observed. Although we cannot rule 
out the possibility of undetected deficits, such as demyelina-
tion and/or disorganization of the spike initiation zone (e.g., 
Wan and Corfas 2017) or alterations in medial or lateral 
efferent innervation (Ruan et al. 2014), our observation that 
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ABR wave I latencies were unchanged by IDPN exposure 
argues against these possibilities.
While this observation does not per se suggest that the 
auditory synapses are more vulnerable than OHCs to IDPN 
exposure, experiments examining the recovery of auditory 
thresholds and suprathreshold responses following cessa-
tion of IDPN exposure suggest greater vulnerability of the 
synapses. Specifically, following cessation of IDPN admin-
istration, ABR wave I absolute thresholds showed recov-
ery (albeit incomplete in tonotopic regions at and above 
24 kHz), whereas ABR wave I suprathreshold amplitudes 
continued to worsen (decrease). Ultimately, suprathreshold 
amplitudes recovered to their baseline (preexposure) val-
ues, and the recuperation of ABR wave I absolute thresholds 
shows almost a complete recovery as well. Normal ABR 
wave I absolute thresholds with reduced suprathreshold 
amplitudes, for example following noise exposure, has been 
interpreted as evidence of cochlear synaptopathy—hearing 
impairment resulting from disrupted function and/or loss 
of the synapses between the IHCs and type I SGNs (Liber-
man and Kujawa 2017; Moser and Starr 2016). Thus, our 
observation of worsening suprathreshold ABR wave I ampli-
tudes despite improving ABR wave I absolute thresholds is 
consistent with functional pathology of the synapses. Func-
tional pathology of the OHCs, on the other hand, would not 
be expected to yield this phenotype. Our observations of 
hearing impairments consistent with cochlear synaptopathy 
following IDPN exposure suggest that synaptic uncoupling 
may be an early phase of cochlear synaptopathy. Synaptic 
uncoupling may be more difficult to discern in the bouton-
shaped afferent terminals in the cochlea compared to the 
calyx-shaped afferent terminals in the vestibule.
Ultimately, we found that auditory function recov-
ered fully if IDPN administration was stopped before 
evidence of morphological pathology, including loss of 
outer hair cells and auditory synapses. Importantly, we 
cannot exclude the possibility that more subtle molecular 
pathology, such as ion channel or myelin reorganization, 
went unobserved in our experiments and contributed to 
IDPN-induced pathophysiology. Nevertheless, we suspect 
that disruption of adhesion complexes between the IHCs 
and type I SGN afferent terminals (synaptic uncoupling) 
may be the earliest and still reversible stage of IDPN-
induced ototoxicity. We further suspect that functional 
recovery is no longer possible after synaptic uncoupling 
has progressed to morphological pathology evidenced by 
loss of synapses. Future work is necessary to substanti-
ate these speculations and should additionally examine 
if there are differences in vulnerability among subgroups 
of afferent synapses (as has been reported in response to 
noise-induced synaptopathy: Liberman and Kujawa 2017). 
Finally, additional work should examine IDPN-induced 
pathology of the efferent synapses contacting the OHCs, 
especially in comparison to the time course of OHC loss. 
These efferent synapses are known to be susceptible to 
gentamicin-induced damage independently of OHC loss 
(Ruan et al. 2014).
Moreover, our comparison of pathology between end 
organs of the inner ear indicated greater vulnerability of 
the cochlea than vestibule in response to IDPN exposure. 
This finding would be better corroborated using equivalent 
measures of auditory and vestibular function. Thus, future 
work should additionally investigate vestibular function 
using measurements of vestibular evoked potentials (e.g. 
Braude et al. 2015). Indeed, earlier work comparing ABRs 
and VsEPs showed strain-dependent differences in the 
vulnerability to age-related loss of auditory and vestibu-
lar function in mouse (Jones et al. 2006). Genetic factors 
likely contribute to differences in the relative severity and 
rate of loss of function between the auditory and vestibular 
end organs. Thus, our work establishes a model in which 
the molecular mechanisms that alter the intrinsic vulner-
ability to ototoxicity can be identified and manipulations 
targeting these mechanisms to protect against inner ear 
damage can be tested.
In conclusion, this work identifies previously unrec-
ognized forms of IDPN-induced damage in the cochlea 
that results in synaptopathy, likely due to uncoupling of 
the IHCs and type I SGN afferent terminals. Importantly, 
the earliest stages of IDPN-induced synaptopathy were 
reversible. Future work is needed to identify the under-
lying molecular mechanisms, especially of these earliest 
and reversible stages. Identification of these mechanisms 
would guide development of novel therapeutic strategies to 
protect against hearing loss in response to ototoxic agents 
and other forms of acquired hearing loss.
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